Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA’s Revamped Research Awards Aim To Encourage Alzheimer’s “Ecosystem”

Executive Summary

Shifting the program from the Discoverers Award, which focused solely on industry achievements, to broader honors acknowledges that “finding the Alzheimer's treatment that works is a tremendous task” which requires “collaboration with our partners” in the scientific and patient advocacy communities, PhRMA President Castellani says.

You may also be interested in...



In Vaccines, PhRMA Celebrates Challenges As Much As Success

At the organization’s Research and Hope Awards, the academics won for products that are already on the market, and the pharmaceutical company won for the vaccine that’s still in development.

Beyond Bapi: Alzheimer’s Pipeline Runs Deep

With the failure of the second of four Janssen-led Phase III trials testing bapineuzumab, partners Janssen and Pfizer have elected to discontinue the bapineuzumab I.V. clinical development program. Nonetheless, the anti-amyloid-beta approach is still alive, as the field turns to early, pre-symptomatic intervention.

US FDA Commissioner Nominee Hahn On Fast Track With 20 November Hearing

Stephen Hahn will go before the Senate health committee less than three weeks after being nominated. Pink Sheet's historical charts illustrate how a long wait and a quick hearing could mean a rapid confirmation.

Topics

Related Companies

UsernamePublicRestriction

Register

PS054735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel